SOTA08 - New RCT Designs: Stepped Wedge, Registry-Based, Trials-Within-Cohorts
Marc Besselink (1976) is the professor of Pancreatic and Hepatobiliary (HPB) surgery at Amsterdam. UMC, University of Amsterdam, the Netherlands. He studied at Utrecht University (Medicine) and Oxford University (Evidence Based Health Care). In 2002, he co-founded the Dutch Pancreatitis Study Group, in 2012 the Dutch Pancreatic Cancer Group, and in 2016 the European Consortium on Minimally Invasive Pancreatic Surgery. He was trained as a surgeon in Utrecht, Amsterdam, and Southampton. Marc has designed and coordinated multiple randomized controlled multicenter trials in acute pancreatitis and pancreatic cancer. He is the current chair of the scientific committee of the Dutch Pancreatic Cancer Group and Dutch Pancreatic Cancer Audit, Dutch Pancreas Biobank. Marc is the 2021-2022 President-Elect of EAHPBA and the Chairman of the Innovation sub-committee of IHPBA. You can follow Marc on Twitter @MarcBesselink.